Retrospective analysis of systemic sclerosis (SSc) pts w/ HRCT proven ILD compared pts Rx w/ tofacitinib (n=9) >6mos

Aug 28, 2023 11:00 am
Social Author Image
https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg
Tweet Author
Dr. John Cush
Social Author Name
RheumNow
Tweet Content
Retrospective analysis of systemic sclerosis (SSc) pts w/ HRCT proven ILD compared pts Rx w/ tofacitinib (n=9) >6mos vs 35 matched SSc-ILD Rx conventional meds. TOFA pts had improved Skin (mRSS), DLCO, HRCT fibrosis scores vs controls https://t.co/xGVzf7L0IP https://t.co/8qHnQ2kQx6
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2023 All Rights Reserved.

×